Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10431156rdf:typepubmed:Citationlld:pubmed
pubmed-article:10431156lifeskim:mentionsumls-concept:C0008377lld:lifeskim
pubmed-article:10431156lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:10431156lifeskim:mentionsumls-concept:C0023824lld:lifeskim
pubmed-article:10431156lifeskim:mentionsumls-concept:C1156530lld:lifeskim
pubmed-article:10431156lifeskim:mentionsumls-concept:C0871935lld:lifeskim
pubmed-article:10431156pubmed:issue8lld:pubmed
pubmed-article:10431156pubmed:dateCreated1999-9-2lld:pubmed
pubmed-article:10431156pubmed:abstractTextAlthough low-density lipoprotein (LDL) receptors regulate the disposition of two-thirds of circulating serum LDL cholesterol, non-LDL receptor mechanisms account for removal of one-third. Here, Carl Alving and Nabila Wassef propose that naturally occurring antibodies to cholesterol in normal human plasma also contribute to LDL cholesterol turnover by opsonizing LDL and other lipoproteins containing 'bad' cholesterol for removal by complement receptors.lld:pubmed
pubmed-article:10431156pubmed:languageenglld:pubmed
pubmed-article:10431156pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10431156pubmed:citationSubsetIMlld:pubmed
pubmed-article:10431156pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10431156pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10431156pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10431156pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10431156pubmed:statusMEDLINElld:pubmed
pubmed-article:10431156pubmed:monthAuglld:pubmed
pubmed-article:10431156pubmed:issn0167-5699lld:pubmed
pubmed-article:10431156pubmed:authorpubmed-author:AlvingC RCRlld:pubmed
pubmed-article:10431156pubmed:authorpubmed-author:WassefN MNMlld:pubmed
pubmed-article:10431156pubmed:issnTypePrintlld:pubmed
pubmed-article:10431156pubmed:volume20lld:pubmed
pubmed-article:10431156pubmed:ownerNLMlld:pubmed
pubmed-article:10431156pubmed:authorsCompleteYlld:pubmed
pubmed-article:10431156pubmed:pagination362-6lld:pubmed
pubmed-article:10431156pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:10431156pubmed:meshHeadingpubmed-meshheading:10431156...lld:pubmed
pubmed-article:10431156pubmed:meshHeadingpubmed-meshheading:10431156...lld:pubmed
pubmed-article:10431156pubmed:meshHeadingpubmed-meshheading:10431156...lld:pubmed
pubmed-article:10431156pubmed:meshHeadingpubmed-meshheading:10431156...lld:pubmed
pubmed-article:10431156pubmed:meshHeadingpubmed-meshheading:10431156...lld:pubmed
pubmed-article:10431156pubmed:meshHeadingpubmed-meshheading:10431156...lld:pubmed
pubmed-article:10431156pubmed:meshHeadingpubmed-meshheading:10431156...lld:pubmed
pubmed-article:10431156pubmed:meshHeadingpubmed-meshheading:10431156...lld:pubmed
pubmed-article:10431156pubmed:meshHeadingpubmed-meshheading:10431156...lld:pubmed
pubmed-article:10431156pubmed:year1999lld:pubmed
pubmed-article:10431156pubmed:articleTitleNaturally occurring antibodies to cholesterol: a new theory of LDL cholesterol metabolism.lld:pubmed
pubmed-article:10431156pubmed:affiliationWalter Reed Army Institute of Research, Dept of Membrane Biochemistry, Washington, DC 20307-5100, USA. carl.alving@na.amedd.army.millld:pubmed
pubmed-article:10431156pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10431156pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10431156lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10431156lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10431156lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10431156lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10431156lld:pubmed